Choosing a laboratory information system has never carried more strategic weight than it does today. The platforms labs select in 2026 will determine not just how efficiently they process cases today, but whether they are positioned to adopt AI-powered diagnostics, support remote pathologist workflows, scale case volume without proportional staff growth, and meet the evolving documentation requirements of an increasingly complex reimbursement landscape.
The Top Laboratory Information Systems in 2026
NovoPath
NovoPath is a true software-as-a-service LIS built specifically for anatomic pathology, molecular diagnostics, and veterinary pathology laboratories. Delivered on Microsoft's cloud infrastructure and certified SOC 2 Type II, the platform is designed around a workflow-first philosophy that treats digital pathology integration as a core function rather than an optional module.
The platform's approach to digital pathology is one of its most distinctive characteristics. Rather than requiring pathologists to navigate between a separate digital viewer and the LIS, NovoPath synchronizes imaging, reporting, and case management in real time within a single environment. This eliminates the fragmentation that characterizes viewer-first architectures and enables labs to build digital pathology workflows that are genuinely sustainable at scale.
NovoPath integrates with more than 150 electronic medical record systems and is platform-agnostic with respect to digital viewers, scanners, and third-party tools, meaning labs are not forced into a proprietary ecosystem. The system supports voice dictation, automated case assignment, configurable reflex testing rules, and fully customizable reporting. Labs that have implemented the platform report meaningful capacity gains, with some handling significant case volume growth without adding staff.
LigoLab
LigoLab takes a different architectural approach to the LIS market, building its platform as a unified system that combines laboratory information management and revenue cycle management on a single integrated architecture. Rather than treating billing as a downstream system connected by interfaces, LigoLab's design ties laboratory operations directly to financial workflows, with the goal of preventing billing errors at the point of origination rather than correcting them after the fact.
This architecture has clear advantages for pathology groups and multi-facility operations that process large case volumes where billing complexity is significant. When the LIS and RCM operate as one system, the data required for accurate claims submission is captured as part of the clinical workflow rather than transcribed into a separate billing platform. LigoLab is used by multi-facility pathology groups processing millions of accessions annually and supports clinical, anatomic pathology, and molecular diagnostic disciplines within a single platform instance.
LigoLab is particularly well-suited for labs where the integration of operational and financial workflows is a primary strategic concern, and for organizations that prefer to manage a single platform rather than coordinating between a separate LIS and billing system. Laboratories that prioritize deep anatomic pathology domain specialization or digital pathology integration as their primary LIS requirements may find it useful to compare LigoLab's capabilities in those specific areas against dedicated AP-focused platforms.
Epic Beaker
For health systems that have standardized on the Epic electronic health record, Beaker offers a compelling argument based primarily on integration depth. As the laboratory module within the Epic ecosystem, Beaker shares patient data, order workflows, and clinical records with the broader Epic platform in ways that no third-party LIS can replicate through an interface alone. For organizations where the EMR is the dominant technology investment and tight clinical workflow alignment is the priority, this integration advantage is real and meaningful.
Epic Beaker supports both clinical pathology and anatomic pathology workflows and benefits from Epic's substantial presence in the United States health system market, including a mature instrument interface library and broad support for point-of-care testing. It is also updated within Epic's regular release cadence, meaning improvements and compliance updates are delivered as part of the health system's existing Epic maintenance relationship.
The primary consideration for labs evaluating Beaker is that its strengths are most apparent within large health system environments that have already committed to the Epic ecosystem. Independent commercial labs, private pathology groups, and specialty labs without existing Epic infrastructure are unlikely to find Beaker the natural fit it is for Epic-anchored health systems.
Oracle Health CoPathPlus
CoPathPlus has a long history in hospital-based anatomic pathology and remains one of the most widely deployed AP systems in that setting, now operating under Oracle Health following Oracle's acquisition of Cerner. For organizations already running Cerner solutions across their clinical infrastructure, CoPathPlus offers familiarity, established support relationships, and a roadmap tied to Oracle's broader enterprise health platform strategy.
Oracle's current focus is on integrating its Cerner assets into a larger data and interoperability infrastructure, which has implications for how CoPathPlus will evolve. Labs evaluating CoPathPlus should assess both the current capabilities of the platform and Oracle Health's stated direction for the product, to ensure that the platform's trajectory aligns with the lab's own digital pathology and AI integration plans over a multi-year horizon.
CoPathPlus is most commonly shortlisted by hospital-based pathology departments that are embedded within Cerner-standardized health systems and for whom continuity with existing vendor relationships carries significant weight.
Clinisys
Clinisys is a large enterprise vendor that has consolidated a number of well-established laboratory software brands, including Sunquest and PowerPath, into a broader platform strategy. Its scale and depth of market presence make it a frequent shortlist entry for hospital and health system environments, particularly those seeking a vendor with breadth across multiple laboratory disciplines and a stable long-term support commitment.
Clinisys is actively working to modernize its platform portfolio, and its established footprint in large institutions gives it a degree of enterprise credibility that newer entrants cannot claim. Labs evaluating Clinisys should examine which specific platform within the Clinisys portfolio best matches their workflow requirements, and assess how the modernization roadmap aligns with their digital pathology and technology adoption plans. The legacy nature of some Clinisys products means that the sophistication of the platform can vary depending on which product line a lab is actually deploying.
CGM LABDAQ
CGM LABDAQ from CompuGroup Medical is a well-regarded LIS for clinical laboratories that prioritizes strong connectivity, practical scalability, and reliable performance. It has a track record of broad deployment across physician office labs, hospital outreach programs, and reference laboratories, and is frequently cited for its interoperability with EHR and practice management systems.
LABDAQ's strengths are most evident in clinical laboratory environments where connectivity, reliability, and the ability to scale through incremental module additions are the primary requirements. Labs seeking deep anatomic pathology specialization, native digital pathology integration, or next-generation AI readiness as their primary differentiators may find LABDAQ better suited as a clinical LIS component within a larger technology stack rather than a standalone AP-focused platform.
LabOS
LabOS is a cloud-native LIS positioning itself as an AI-driven platform for modern diagnostic laboratories. Built on a fully cloud-based SaaS architecture with an emphasis on fast implementation timelines, automated workflows, and scalability, LabOS appeals to labs that want a modern technology foundation with the flexibility to adapt workflows as their operational needs evolve.
The platform's focus on automation, decision support, and AI-capable architecture makes it a relevant option for labs that are planning meaningful technology investment over the near term and want a system built for a digital-first operating model. LabOS is gaining traction among labs that have found legacy platforms constraining and are looking for a more agile foundation without the complexity of some enterprise systems. As a relatively newer entrant compared to vendors with decades of anatomic pathology implementation history, prospective customers should evaluate the depth of specialty support in their specific disciplines alongside the platform's technology credentials.
Evaluating the Right Fit for Your Lab
No single platform is the right choice for every laboratory, and the most honest thing any evaluation guide can offer is a clear framework for matching platform strengths to specific lab requirements.
The features that will matter most in the next three to five years, digital pathology integration depth, AI readiness, cloud-native scalability, and interoperability with an expanding technology ecosystem, are not evenly distributed across the platforms in this market. Labs that evaluate those capabilities seriously, rather than focusing solely on current feature lists, will make decisions that serve them well as the demands on laboratory operations continue to grow.
The best healthcare laboratory information system is not necessarily the most well-known one or the one with the longest feature list. It is the one whose architecture, specialty focus, and implementation approach align most closely with where your laboratory needs to be.
